Arrowhead Pharmaceuticals Statistics

Total Valuation

ARWR has a market cap or net worth of $2.42 billion. The enterprise value is $2.59 billion.

Market Cap	2.42B
Enterprise Value	2.59B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025, after market close.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	n/a

Share Statistics

ARWR has 124.43 million shares outstanding. The number of shares has increased by 12.21% in one year.

Current Share Class	124.43M
Shares Outstanding	124.43M
Shares Change (YoY)	+12.21%
Shares Change (QoQ)	+0.13%
Owned by Insiders (%)	3.93%
Owned by Institutions (%)	71.72%
Float	110.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	19.04
PB Ratio	13.04
P/TBV Ratio	13.68
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	730.70
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.74, with a Debt / Equity ratio of 4.46.

Current Ratio	6.74
Quick Ratio	6.57
Debt / Equity	4.46
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-18.58

Financial Efficiency

Return on equity (ROE) is -254.98% and return on invested capital (ROIC) is -43.85%.

Return on Equity (ROE)	-254.98%
Return on Assets (ROA)	-39.43%
Return on Capital (ROIC)	-43.85%
Revenue Per Employee	$5,831
Profits Per Employee	-$984,389
Employee Count	609
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	-2.77M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.17% in the last 52 weeks. The beta is 0.93, so ARWR's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	-35.17%
50-Day Moving Average	21.10
200-Day Moving Average	23.71
Relative Strength Index (RSI)	39.30
Average Volume (20 Days)	2,249,379

Short Selling Information

The latest short interest is 10.07 million, so 8.09% of the outstanding shares have been sold short.

Short Interest	10.07M
Short Previous Month	9.45M
Short % of Shares Out	8.09%
Short % of Float	9.10%
Short Ratio (days to cover)	8.94

Income Statement

In the last 12 months, ARWR had revenue of $3.55 million and -$599.49 million in losses. Loss per share was -$5.00.

Revenue	3.55M
Gross Profit	3.55M
Operating Income	-601.08M
Pretax Income	-539.92M
Net Income	-599.49M
EBITDA	-582.49M
EBIT	-601.08M
Loss Per Share	-$5.00

Full Income Statement

Balance Sheet

The company has $677.46 million in cash and $851.91 million in debt, giving a net cash position of -$174.45 million or -$1.40 per share.

Cash & Cash Equivalents	677.46M
Total Debt	851.91M
Net Cash	-174.45M
Net Cash Per Share	-$1.40
Equity (Book Value)	191.06M
Book Value Per Share	1.49
Working Capital	592.30M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$462.85 million and capital expenditures -$141.47 million, giving a free cash flow of -$604.32 million.

Operating Cash Flow	-462.85M
Capital Expenditures	-141.47M
Free Cash Flow	-604.32M
FCF Per Share	-$4.86

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-16,927.06%
Pretax Margin	-17,247.54%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARWR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.21%
Shareholder Yield	-12.21%
Earnings Yield	-24.77%
FCF Yield	-24.97%

Dividend Details

Analyst Forecast

The average price target for ARWR is $42.70, which is 119.54% higher than the current price. The consensus rating is "Buy".

Price Target	$42.70
Price Target Difference	119.54%
Analyst Consensus	Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	219.11%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on November 17, 2011. It was a reverse split with a ratio of 0.1:1.

Last Split Date	Nov 17, 2011
Split Type	Reverse
Split Ratio	0.1:1

Scores

ARWR has an Altman Z-Score of -1.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.08
Piotroski F-Score	2